参考文献 (References)[1] M. S. Balayan, A. G. Andjaparidze, S. S. Savinskaya, et al. Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route. Intervirology, 1983, 20(1): 23-31.
[2] X. J. Meng. Hepatitis E virus: Animal reservoirs and zoonotic risk. Veterinary Microbiology, 2010, 140(3-4): 256-65.
[3] H. Ma, L. Zheng, Y. Liu, et al. Experimental infection of rabbits with rabbit and genotypes 1 and 4 hepatitis E viruses. PLoS One, 2010, 5(2): e9160.
[4] J. M. Peron, C. Bureau, H. Poirson, et al. Fulminant liver failure from acute autochthonous hepatitis E in France: Description of seven patients with acute hepatitis E and encephalopathy. Journal of Viral Hepatitis, 2007, 14(5): 298-303.
[5] N. Kamar, C. Garrouste, E. B. Haagsma, et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology, 2011, 140(5): 1481-9.
[6] F. F. Huang, Z. F. Sun, S. U. Emerson, et al. Determination and analysis of the complete genomic sequence of avian hepatitis E virus (avian HEV) and attempts to infect rhesus monkeys with avian HEV. Journal of General Virology, 2004, 85(6): 1609- 1618.
[7] E. V. Koonin, A. E. Gorbalenya, M. A. Purdy, et al. Computerassisted assignment of functional domains in the nonstructural polyprotein of hepatitis E virus: Delineation of an additional group of positive-strand RNA plant and animal viruses. Proceedings of the National Academy of Sciences, 1992, 89(17): 8259-8263.
[8] T. C. Li, Y. Yamakawa, K. Suzuki, et al. Expression and selfassembly of empty virus-like particles of hepatitis E virus. Journal of Virology, 1997, 71(10): 7207-7213.
[9] S. U. Emerson, H. T. Nguyen, U. Torian, et al. Release of genotype 1 hepatitis E virus from cultured hepatoma and polarized intestinal cells depends on open reading frame 3 protein and requires an intact PXXP motif. Journal of Virology, 2010, 84(18): 9059-9069.
[10] D. Cao, Y. W. Huang and X. J. Meng. The nucleotides on the stem-loop RNA structure in the junction region of the hepatitis E virus genome are critical for virus replication. Journal of Virology, 2010, 84(24): 13040-13044.
[11] S. U. Emerson, M. Zhang, X. J. Meng, et al. Recombinant hepatitis E virus genomes infectious for primates: importance of capping and discovery of a Cis-reactive element. Proceedings of the National Academy of Sciences, 2001, 98(26): 15270-15275.
[12] J. Magden, N. Takeda, T. Li, et al. Virus-specific mRNA capping enzyme encoded by hepatitis E virus. Journal of Virology, 2001, 75(14): 6249-6455.
[13] Y. A. Karpe and K. S. Lole. RNA 5’-triphosphatase activity of the hepatitis E virus helicase domain. Journal of Virology, 2010, 84(18): 9637-9641.
[14] Y. A. Karpe and K. S. Lole. NTPase and 5’ to 3’ RNA duplex-unwinding activities of the hepatitis E virus helicase domain. Journal of Virology, 2010, 84(7): 3595-3602.
[15] S. L. Ropp, A. W. Tam, B. Beames, et al. Expression of the hepatitis E virus ORF1. Archives of Virology, 2000, 145(7): 1321-1337.
[16] D. Sehgal, S. Thomas, M. Chakraborty, et al. Expression and processing of the Hepatitis E virus ORF1 nonstructural polyprotein. Journal of Virology, 2006, 3: 38.
[17] Y. A. Karpe and K. S. Lole. Deubiquitination activity associated with hepatitis E virus putative papain-like cysteine protease. Journal of General Virology, 2011, 92(9): 2088-2092.
[18] S. Agrawal, D. Gupta and S. K. Panda. The 3’ end of hepatitis E virus (HEV) genome binds specifically to the viral RNAdependent RNA polymerase (RdRp). Virology, 2001, 282(1): 87-101.
[19] S. Rehman, N. Kapur, H. Durgapal, et al. Subcellular localization of hepatitis E virus (HEV) replicase. Virology, 2008, 370(1): 77-92.
[20] R. S. Pudupakam, Y. W. Huang, T. Opriessnig, et al. Deletions of the hypervariable region (HVR) in open reading frame 1 of hepatitis E virus do not abolish virus infectivity: Evidence for attenuation of HVR deletion mutants in vivo. Journal of Virology, 2009, 83(1): 384-395.
[21] R. S. Pudupakam, S. P. Kenney, L. Cordoba, et al. Mutational analysis of the hypervariable region of hepatitis e virus reveals its involvement in the efficiency of viral RNA replication. Journal of Virology, 2011, 85(19): 10031-10040.
[22] X. J. Meng. Recent advances in Hepatitis E virus. Journal of Viral Hepatitis, 2010, 17(3): 153-161.
[23] S. Jameel, M. Zafrullah, M. H. Ozdener, et al. Expression in animal cells and characterization of the hepatitis E virus structural proteins. Journal of Virology, 1996, 70(1): 207-16.
[24] M. Surjit, S. Jameel and S. K. Lal. Cytoplasmic localization of the ORF2 protein of hepatitis E virus is dependent on its ability to undergo retrotranslocation from the endoplasmic reticulum. Journal of Virology, 2007, 81(7): 3339-3345.
[25] J. Graff, Y. H. Zhou, U. Torian, et al. Mutations within potential glycosylation sites in the capsid protein of hepatitis E virus prevent the formation of infectious virus particles. Journal of Virology, 2008, 82(3): 1185-1194.
[26] M. Surjit, S. Jameel and S. K. Lal. The ORF2 protein of hepatitis E virus binds the 5’ region of viral RNA. Journal of Virology, 2004, 78(1): 320-328.
[27] Z. Z. Zheng, J. Miao, M. Zhao, et al. Role of heat-shock protein 90 in hepatitis E virus capsid trafficking. Journal of Viral Hepatitis, 2010, 91(7): 1728-1736.
[28] H. Yu, S. Li, C. Yang, et al. Homology model and potential virus-capsid binding site of a putative HEV receptor Grp78. Journal of Molecular Modeling, 2011, 17(5): 987-995.
[29] M. Kalia, V. Chandra, S. A. Rahman, et al. Heparan sulfate proteoglycans are required for cellular binding of the hepatitis E virus ORF2 capsid protein and for viral infection. Journal of Virology, 2009, 83(24): 12714-12724.
[30] D. J. Schofield, J. Glamann, S. U. Emerson, et al. Identification by phage display and characterization of two neutralizing chimpanzee monoclonal antibodies to the hepatitis E virus capsid protein. Journal of Virology, 2000, 74(12): 5548-5555.
[31] J. Meng, X. Dai, J. C. Chang, et al. Identification and characterization of the neutralization epitope(s) of the hepatitis E virus. Virology, 2001, 288(2): 203-211.
[32] Y. H. Zhou, R. H. Purcell and S. U. Emerson. An ELISA for putative neutralizing antibodies to hepatitis E virus detects antibodies to genotypes 1, 2, 3, and 4. Vaccine, 2004, 22(20): 2578-2585.
[33] J. Zhang. Randomized-controlled phase II clinical trial of a bacterially expressed recombinant hepatitis E vaccine. Vaccine, 2009, 27: 1869-1874.
[34] M. P. Shrestha. Safety and efficacy of a recombinant hepatitis E vaccine. The New England Journal of Medicine, 2007, 356: 895-903.
[35] H. Zhang, X. Dai, X. Shan, et al. The Leu477 and Leu613 of ORF2-encoded protein are critical in forming neutralization antigenic epitope of hepatitis E virus genotype 4. Cellular & Molecular Immunology, 2008, 5(6): 447-456.
[36] J. Graff, U. Torian, H. Nguyen, et al. A bicistronic subgenomic mRNA encodes both the ORF2 and ORF3 proteins of hepatitis E virus. Journal of Virology, 2006, 80(12): 5919-5926.
[37] I. Ahmad, R. P. Holla and S. Jameel. Molecular virology of hepatitis E virus. Virus Research, 2011, 161(1): 47-58.
[38] M. Zafrullah, M. H. Ozdener, S. K. Panda, et al. The ORF3 protein of hepatitis E virus is a phosphoprotein that associates with the cytoskeleton. Journal of Virology, 1997, 71(12): 9045-9053.
[39] A. Kar-Roy, H. Korkaya, R. Oberoi, et al. The hepatitis E virus open reading frame 3 protein activates ERK through binding and inhibition of the MAPK phosphatase. The Journal of Biological Chemistry, 2004, 279(27): 28345-28357.
[40] H. Kannan, S. Fan, D. Patel, et al. The hepatitis E virus open reading frame 3 product interacts with microtubules and interferes with their dynamics. Journal of Virology, 2009, 83(13): 6375-6382.
[41] R. Ratra, A. Kar-Roy and S. K. Lal. The ORF3 protein of hepatitis E virus interacts with hemopexin by means of its 26 amino acid N-terminal hydrophobic domain II. Biochemistry, 2008, 47(7): 1957-1969.
[42] Y. Zhu, Z. Li and C. Bu. The open reading frame 2 initiation site of genotype 4 hepatitis E virus (HEV). Infection, Genetics and Evolution, 2012, 12(3): 502-503.
[43] S. Tyagi, H. Korkaya, M. Zafrullah, et al. The phosphorylated form of the ORF3 protein of hepatitis E virus interacts with its non-glycosylated form of the major capsid protein, ORF2. The Journal of Biological Chemistry, 2002, 277(25): 22759-22767.
[44] K. Yamada, M. Takahashi, Y. Hoshino, et al. ORF3 protein of hepatitis E virus is essential for virion release from infected cells. Journal of General Virology, 2009, 90(8): 1880-1891.
[45] M. Surjit, R. Oberoi, R. Kumar, et al. Enhanced alpha1 microglobulin secretion from Hepatitis E virus ORF3-expressing human hepatoma cells is mediated by the tumor susceptibility gene 101. The Journal of Biological Chemistry, 2006, 281(12): 8135-8142.
[46] H. Ma, X. Song, T. J. Harrison, et al. Hepatitis E virus ORF3 antigens derived from genotype 1 and 4 viruses are detected with varying efficiencies by an anti-HEV enzyme immunoassay. Journal of Medical Virology, 2011, 83(5): 827-832.
[47] H. Ma, X. Song, T. J. Harrison, et al. Immunogenicity and efficacy of a bacterially expressed HEV ORF3 peptide, assessed by experimental infection of primates. Archives of Virology, 2009, 154(10): 1641-1648.
[48] J. Graff, H. Nguyen, C. Kasorndorkbua, et al. In vitro and in vivo mutational analysis of the 3’-terminal regions of hepatitis e virus genomes and replicons. Journal of Virology, 2005, 79(2): 1017- 1026.
[49] J. Graff, H. Nguyen, C. Yu, et al. The open reading frame 3 gene of hepatitis E virus contains a Cis-reactive element and encodes a protein required for infection of macaques. Journal of Virology, 2005, 79(11): 6680-6689.